ABIN2842896

antibody from antibodies-online

Targeting: FANCC FA3, FAC, FACC

Provider product page for ABIN2842896

Western blot

Immunocytochemistry

Immunohistochemistry

Flow cytometry

Antibody data

Antibody Data
Antigen structure
References [4]
Comments [0]
Validations
Western blot [1]
Immunohistochemistry [1]
Flow cytometry [1]

Submit

Product number: ABIN2842896 - Provider product page
Provider: antibodies-online
Product name: anti-Fanconi Anemia, Complementation Group C (FANCC) (AA 527-555), (C-Term) antibody
Antibody type: Polyclonal
Description: This antibody is purified through a protein A column, followed by peptide affinity purification.
Reactivity: Human
Host: Rabbit
Epitope: AA 527-555, C-Term
Antibody clone number: RB24076
Vial size: 80 μL
Storage: Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

FANCC protein structure - ABIN2842896 shown in red.

Submitted references Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk.

McWilliams RR, Bamlet WR, de Andrade M, Rider DN, Couch FJ, Cunningham JM, Matsumoto ME, Rabe KG, Hammer TJ, Petersen GM
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Sep;18(9):2549-52

Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk.

Michiels S, Laplanche A, Boulet T, Dessen P, Guillonneau B, Méjean A, Desgrandchamps F, Lathrop M, Sarasin A, Benhamou S
Carcinogenesis 2009 May;30(5):763-8

Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma.

Sinha S, Singh RK, Alam N, Roy A, Roychoudhury S, Panda CK
Molecular cancer 2008 Nov 6;7:84

Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.

Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole C, Anderson AR, Anderson S, Anton-Culver H, Beesley J, Hogdall E, Brewster W, Carney ME, Chen X, Chenevix-Trench G, Chang-Claude J, Cunningham JM, Dicioccio RA, Doherty JA, Easton DF, Edlund CK, Gayther SA, Gentry-Maharaj A, Goode EL, Goodman MT, Kjaer SK, Hogdall CK, Hopkins MP, Jenison EL, Blaakaer J, Lurie G, McGuire V, Menon U, Moysich KB, Ness RB, Pearce CL, Pharoah PD, Pike MC, Ramus SJ, Rossing MA, Song H, Terada KY, Vandenberg D, Vierkant RA, Wang-Gohrke S, Webb PM, Whittemore AS, Wu AH, Ziogas A, Berchuck A, Schildkraut JM, Ovarian Cancer Association Consortium., Australian Cancer Study (Ovarian Cancer Group)., Australian Ovarian Cancer Study Group.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Dec;17(12):3567-72